RBC

Government of Canada announces appointments to the Independent Advisory Board for Senate Appointments

Retrieved on: 
Tuesday, January 23, 2024
Teck Resources, Senior, Counsel, Senate, Superior court, University, King's Counsel, McGill University, RBC, Teck, Regional municipality, Advisory board, Public security

OTTAWA, ON, Jan. 23, 2024 /CNW/ - Today, the Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions, and Intergovernmental Affairs, announced appointments to the Independent Advisory Board for Senate Appointments (the Advisory Board).

Key Points: 
  • OTTAWA, ON, Jan. 23, 2024 /CNW/ - Today, the Honourable Dominic LeBlanc, Minister of Public Safety, Democratic Institutions, and Intergovernmental Affairs, announced appointments to the Independent Advisory Board for Senate Appointments (the Advisory Board).
  • The Advisory Board is an independent and non-partisan body mandated to provide the Prime Minister with merit-based, non-binding recommendations on Senate appointments.
  • Advisory Board appointments for jurisdictions with current and upcoming vacancies in the Senate will be announced in due course.
  • The Advisory Board will continue to be chaired by Ms. Huguette Labelle, Emeritus Governor of the University of Ottawa and former Deputy Minister with the Government of Canada.

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics

Retrieved on: 
Wednesday, January 17, 2024
Vertex Pharmaceuticals, Patient, Biologics license application, Therapy, Endocrine system, TGF, Heart, LAS, HBA, Spleen, Diagnosis, Anemia, Mouse, Thalassemia, Beta thalassemia, HB, CBC, RBC, Pharmacosmos, Disease, Iron overload, TDT, EU4, FDA, Blas, Prevalence, Liver, Novo Nordisk, PDUFA, Red blood cell, CRISPR Therapeutics, Hemoglobin A, Cell, Iron, Pharmaceutical industry

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Beta-thalassemia Market Insights report includes a comprehensive understanding of current treatment practices, beta-thalassemia emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

Key Points: 
  • According to DelveInsight's analysis, the market size for beta-thalassemia across the 7MM is expected to grow with a significant CAGR by 2032.
  • The promising beta-thalassemia therapies in the pipeline include CTX001, EDIT-301, Mitapivat, ACE-536, Panobinostat, Etavopivat tablets, and others.
  • In September 2023, Pharmacosmos has initiated a Phase II trial of SP-420 in patients with transfusion-dependent β-thalassemia.
  • In June 2023, FDA accepted the Biologics License Application (BLAs) of exagamglogene autotemcel (exa-cel) for transfusion-dependent beta thalassemia (TDT).

Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics

Retrieved on: 
Wednesday, January 17, 2024
Vertex Pharmaceuticals, Patient, Biologics license application, Therapy, Endocrine system, TGF, Heart, LAS, HBA, Spleen, Diagnosis, Anemia, Mouse, Thalassemia, Beta thalassemia, HB, CBC, RBC, Pharmacosmos, Disease, Iron overload, TDT, EU4, FDA, Blas, Prevalence, Liver, Novo Nordisk, PDUFA, Red blood cell, CRISPR Therapeutics, Hemoglobin A, Cell, Iron, Pharmaceutical industry

LAS VEGAS, Jan. 17, 2024 /PRNewswire/ -- DelveInsight's Beta-thalassemia Market Insights report includes a comprehensive understanding of current treatment practices, beta-thalassemia emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan].

Key Points: 
  • According to DelveInsight's analysis, the market size for beta-thalassemia across the 7MM is expected to grow with a significant CAGR by 2032.
  • The promising beta-thalassemia therapies in the pipeline include CTX001, EDIT-301, Mitapivat, ACE-536, Panobinostat, Etavopivat tablets, and others.
  • In September 2023, Pharmacosmos has initiated a Phase II trial of SP-420 in patients with transfusion-dependent β-thalassemia.
  • In June 2023, FDA accepted the Biologics License Application (BLAs) of exagamglogene autotemcel (exa-cel) for transfusion-dependent beta thalassemia (TDT).

RBC Training Ground launches new season as Team Canada prepares for the Paris 2024 Olympic Games

Retrieved on: 
Tuesday, January 16, 2024
Ageing, Gold, Track cycling, Partnership, World championship, Athlete, Olympic Games, Rowing, Canada national team, RBC, COC, Flag, Squash Canada, Cycling Canada, Summer Olympic Games, NSO, Rowing Canada Aviron, Canadian Freestyle Ski Association, Grande Prairie, Dietary supplement

TORONTO, Jan. 16, 2024 /CNW/ - In its search for Canada's next Olympic talent, RBC is calling on young athletes to register for the newest season of RBC Training Ground .

Key Points: 
  • TORONTO, Jan. 16, 2024 /CNW/ - In its search for Canada's next Olympic talent, RBC is calling on young athletes to register for the newest season of RBC Training Ground .
  • With the Paris 2024 Olympic Games fast approaching, as many as 30 RBC Training Ground graduates are in line for spots on Team Canada.
  • This would mark a milestone for the program after five graduates represented Canada at the Beijing 2022 Olympic Games and eight graduates competed at the Tokyo 2020 Olympic Games.
  • RBC Training Ground was developed in partnership with the Canadian Olympic Committee and Canadian Olympic Foundation, with support from the Canadian Olympic and Paralympic Sport Institute Network.

BTIG Promotes Michael Passaro to Head of Equity Capital Markets

Retrieved on: 
Tuesday, January 9, 2024
Banking, Professional Services, Finance, Origination (telephony), Deutsche Bank, UBS, Wells Fargo, ECM, Equity capital markets, RBC, Growth, Security (finance)

BTIG announced that Michael Passaro has been promoted to Head of Equity Capital Markets.

Key Points: 
  • BTIG announced that Michael Passaro has been promoted to Head of Equity Capital Markets.
  • Since joining BTIG in 2020, Mr. Passaro has been instrumental in the expansion and success of the equity capital markets group.
  • “We are excited to promote Michael to Head of Equity Capital Markets,” said Anton LeRoy, Chief Executive Officer of BTIG.
  • As part of that expansion, the firm recently hired Anthony Faria as a Director of Equity Capital Markets where he will help expand the firm’s capital markets origination effort and play a key role in the execution of Equity Capital Markets transactions.

OSC announces Seniors Expert Advisory Committee members for 2024

Retrieved on: 
Wednesday, January 10, 2024
Well, Volunteering, PACE, Ethics, Partner, Face, Abuse, University, Medicine, Salmon, Risk, Banking in Canada, National initiative, CIRO, Consent, Law society, Albert Einstein's brain, Decision, Social work, Old age, Dementia, Law enforcement, Policy, Rights, Law, UN, Environment, TMU, OSC, NASAA, Ageism, Education, Communication, Care, Elder abuse, Royal Bank, Person, RBC, Executive, Memory, Senior, EAPO, Ontario Securities Commission, Toronto Metropolitan University, Government, Trust, Blog, CCAA, United Nations, Nursing

TORONTO, Jan. 10, 2024 /CNW/ - The Ontario Securities Commission (OSC) today announced the membership of its Seniors Expert Advisory Committee (SEAC) for the 2024 term.

Key Points: 
  • TORONTO, Jan. 10, 2024 /CNW/ - The Ontario Securities Commission (OSC) today announced the membership of its Seniors Expert Advisory Committee (SEAC) for the 2024 term.
  • First launched in 2016, SEAC has provided valuable insights on and contributions to OSC initiatives supporting seniors, including the development and implementation of the OSC Seniors Strategy.
  • Members provide diverse perspectives on issues and challenges facing older investors, drawing on their expertise in sectors including financial services, law, law enforcement, academia, medicine and seniors' advocacy.
  • The OSC would like to thank former SEAC members Alexis Wenzowski, Harold Geller, James (Jim) Turner, Kavina Nagrani and Keith Sjorgen for their service and contributions.

Trice Secures Seed Funding from Diagram Ventures, Royal Bank of Canada, and JAM FINTOP to Propel Innovation in Real-Time Bank Payments

Retrieved on: 
Tuesday, January 9, 2024
The Clearing House, JAM, Royal Bank, API, Digital wallet, Clearing house, RTP, Request, Credit union, Private equity, RBC, RFP, Neobank, Royal Bank of Canada, Engineering, Cryptocurrency

This round featured strategic investments from Diagram Ventures, Royal Bank of Canada (RBC), and JAM FINTOP.

Key Points: 
  • This round featured strategic investments from Diagram Ventures, Royal Bank of Canada (RBC), and JAM FINTOP.
  • Steve Schultz, Partner at Diagram Ventures said, "Diagram Ventures is thrilled to lead the seed investment in Trice as part of our commitment to fostering innovation in fintech.
  • Together with co-investors JAM FINTOP and RBC, we are confident in Trice's ability to enable high-impact use cases for real-time payments.
  • "Trice is a leading real-time payments gateway company, and we recognize the potential of Trice's innovative platform to revolutionize the payments landscape.

Cerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business Update

Retrieved on: 
Monday, January 8, 2024
Biotechnology, General Health, Hospitals, Health, Medical Supplies, CE marking, Growth, Corporation, RBC, CERS, Cerus Corporation

Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2023 and provided product revenue guidance for full-year 2024.

Key Points: 
  • Cerus Corporation (Nasdaq: CERS) today announced preliminary product revenue for the fourth quarter and full-year 2023 and provided product revenue guidance for full-year 2024.
  • Cerus’ unaudited preliminary product revenue for the fourth quarter of 2023 totaled $46.8 million, representing an increase of 6% over the $44.0 million recognized during the fourth quarter of 2022 and 18% sequentially.
  • The Company expects its unaudited preliminary full-year 2023 product revenue to be $156.4 million, in line with the Company’s 2023 product revenue guidance range of $155-$158 million.
  • “Additionally, we continue to expect to realize adjusted EBITDA breakeven for the fourth quarter 2023 when we report complete fourth quarter 2023 and year-end results,” continued Greenman.

Ronald McDonald House New York Awarded $1.05 Million Grant from the RBC Foundation USA

Retrieved on: 
Monday, January 8, 2024
Other Health, General Health, Philanthropy, Data Management, Technology, Lodging, Hospitals, Travel, Health Technology, Foundation, Other Technology, Other Philanthropy, Health, Ronald McDonald House Charities, Meal, Partnership, Vulnerable, New Yorker, Digital Solutions, Data, RBC, Hospital, RBC Capital Markets, Health equity, Data warehouse, House, Volunteering, Transport, Organization, New York City Marathon, Child, Nursing

Ronald McDonald House New York (RMH-NY) today announced it has been awarded a $1.05 million grant from the RBC Foundation USA to accelerate RMH-NY's Health Equity Program: Supporting Vulnerable NYC Children & Families.

Key Points: 
  • Ronald McDonald House New York (RMH-NY) today announced it has been awarded a $1.05 million grant from the RBC Foundation USA to accelerate RMH-NY's Health Equity Program: Supporting Vulnerable NYC Children & Families.
  • “We are so grateful to our long-time partner, the RBC Foundation USA, for awarding Ronald McDonald House New York with this generous grant,” said Dr. Ruth C. Browne, president and CEO of Ronald McDonald House New York.
  • “With deep roots in the New York City community, Ronald McDonald House New York is committed to eliminating hardships for all families and ensuring they can remain focused on beating their child’s illness.
  • To learn more about the partnership between Ronald McDonald House New York, the RBC Foundation USA, and RBC Capital Markets, click here .

RUSSEL METALS ANNOUNCES CHANGES TO THE BOARD OF DIRECTORS

Retrieved on: 
Tuesday, January 2, 2024
CPA, Business administration, RBC Dominion Securities, Retirement, RBC, MBA, RBC Capital Markets, University, Harvard University, TSX, Metal, Russel Metals, Management

TORONTO, Jan. 2, 2024 /PRNewswire/ - Russel Metals Inc. (TSX: RUS) announces the retirement of Linh Austin from the Board of Directors and the appointment of Stewart Burton as an independent Director.

Key Points: 
  • TORONTO, Jan. 2, 2024 /PRNewswire/ - Russel Metals Inc. (TSX: RUS) announces the retirement of Linh Austin from the Board of Directors and the appointment of Stewart Burton as an independent Director.
  • Russel Metals' Board Chair Jim Dinning extended his appreciation for Mr. Austin's service and commented "I want to thank Linh for his contributions to our Board and wish him well."
  • Jim Dinning commented, "We welcome Stewart Burton to Russel Metals.
  • Stewart's extensive business experience and his deep knowledge of global capital markets will add to the strength of our Board of Directors and be a benefit to shareholders.